Explore the full record of transactions filed by Ozawa Clare, Director. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 11 disclosures have been logged. Total volume traded: €7.7m. The latest transaction was filed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Clare Ozawa is a Director at Oyster Point Pharma, Inc. In this role, she participates in the governance of the company, providing her expertise in strategy and biopharmaceuticals. Clare plays a key role in the strategic direction of Oyster Point, a company specializing in developing ophthalmic treatments.